HTFL logo

HEARTFLOW INC

HTFLNASDAQ
🏆 #1257 by market capUS Equity
$59.70▲ $0.63 (+1.06%)
Latest quote
🔔
Track HTFL
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 1.1%
7d▲ 7.8%
14d▲ 17.3%
30d▲ 19.8%
ytd▲ 104.7%
1y▲ 59.8%
🏦Market Cap
$5.19B
Small Cap
📈Revenue Growth (YoY)
39.9%
High Growth
📊Gross Margin
80.1%
High
💵FCF Margin
-27.9%
Thin
⚖️P/S Ratio
23.7x
Expensive
Otter Score
60
Fair

Trading Snapshot

Day Range
$58.78 – $60.14
52-Week Range
$20.13 – $59.90
Volume (shares)
8,701
Avg Volume (shares)
—
Shares Outstanding
87.0M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$176M
Last Q Revenue
$64M
P/E Ratio
-40.7
P/S Ratio
23.7x
EPS (TTM)
$-1.37
Dividend Yield
0.00%
Dilution (1yr)
+34.4%
HTFL logo

HEARTFLOW INC

HTFL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$176M▲ +39.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
76.8%▲ +2.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$64M▲ +4.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$59M▼ −19.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
85.3M▲ +34.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$23M▲ +$132M YoY
StockOtter · stockotter.space

About HEARTFLOW INC

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100
Analyst data unavailable.

Latest News & Updates

News unavailable.